REGENXBIO Inc. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: REGENXBIO Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
REGENXBIO Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $9.88M, a 3.28% decline year-over-year.
REGENXBIO Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $37.3M, a 9.87% decline year-over-year.
REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40.3M, a 1.28% decline from 2022.
REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2022 was $40.8M, a 5.1% increase from 2021.
REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2021 was $38.8M, a 21.5% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Annual (USD)

Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$40.3M	-$521K	-1.28%	Jan 1, 2023	Dec 31, 2023	10-K	2024-02-27
2022	$40.8M	+$1.98M	+5.1%	Jan 1, 2022	Dec 31, 2022	10-K	2024-02-27
2021	$38.8M	+$6.86M	+21.5%	Jan 1, 2021	Dec 31, 2021	10-K	2024-02-27
2020	$31.9M	+$5.1M	+19%	Jan 1, 2020	Dec 31, 2020	10-K	2023-02-28
2019	$26.9M	+$10.2M	+61.4%	Jan 1, 2019	Dec 31, 2019	10-K	2022-03-01
2018	$16.6M	+$6.04M	+56.9%	Jan 1, 2018	Dec 31, 2018	10-K	2021-03-01
2017	$10.6M	+$3.57M	+50.8%	Jan 1, 2017	Dec 31, 2017	10-K	2020-02-26
2016	$7.03M	+$4.11M	+141%	Jan 1, 2016	Dec 31, 2016	10-K	2019-02-27
2015	$2.92M	+$2.6M	+816%	Jan 1, 2015	Dec 31, 2015	10-K	2018-03-06
2014	$319K			Jan 1, 2014	Dec 31, 2014	10-K	2017-03-07

Showing 1 to 10 of 10 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.